MD Anderson guides intelligent redesign of cancer care delivery model

February 5, 2014

How best to implement key recommendations recently identified by the Institute of Medicine (IOM) for the delivery of high-quality cancer care is the focus of two peer-reviewed articles from The University of Texas MD Anderson Cancer Center.

Published recently in Healthcare: The Journal of Delivery Science and Innovation and the Journal of the American Medical Informatics Association, the papers elaborate on recommendations in the September 2013 IOM report, Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis.

The papers support the ability to measure and improve national delivery systematically. Specifically, the papers' authors address two areas essential to improving the quality of cancer care in America, including the need to develop:

— A learning information technology (IT) system for cancer that enables real-time data analysis from in a variety of care settings;

and

— A national quality reporting program for cancer care as a part of a learning system.

These needs embody key recommendations first brought to light in a 1999 IOM report on improving the quality of cancer care. Such intelligent systems provide patients and clinicians with the information and tools necessary to make well informed medical decisions, support quality measurement and improve care. With the nation's undergoing rapid transformation precipitated by the Affordable Care Act, the widespread adoption of efforts that result in meaningful, patient-centric outcomes and costs of care are critical.

"It's time to pull back the curtain on cancer quality measurement efforts to date," said Thomas Feeley, M.D., director of MD Anderson's Institute for Cancer Care Innovation and an author on the papers. "Since the IOM recognized the need for a core set of quality measures to improve cancer care nearly 15 years ago, several organizations have made genuine attempts to fill these gaps. But their efforts lacked the breadth magnitude, coordination and sustainability to transform cancer care across the nation."

Potential leadership and management structure

In their analyses, Feeley and colleague, Tracy Spinks, project director of MD Anderson's Clinical Operations, call for federal oversight, ensuring the necessary level of leadership to direct, coordinate and fund nationwide quality efforts. The authors, who also served as contributors to the most recent IOM report, propose that this model would enforce key tasks for the intelligent redesign of cancer care delivery, among them:

Putting the Patient at the Center: Intelligent Redesign of the Cancer Care Delivery Model

Enlist the Centers for Medicare and Medicaid Services, the National Quality Forum and other professional organizations as key partners to align, unify and accelerate quality measurement efforts already underway.

Expand quality measures to include metrics that are meaningful to providers, payers and patients, with the highest priority given to those directly tied to outcomes. Fund health services research and clinical trials that elicit non-technical dimensions of quality cancer care and integrate the patient perspective.

Enhance health care IT systems by partnering with clinicians and the IT industry to collect and report standardized cancer metrics data so that it spurs innovation and improvement. An ideal system supports clinic workflow, powerful data analytics, real-time decision-making, care coordination and patient access.

Establish a public reporting procedure, that emphasizes transparency and that presents data in a way that guides patients and caregivers in their health care decision-making.

The papers also address how important it is to include the perspective of elderly patients in metric development, as well as ensuring access to institutions that care for vulnerable and underserved populations. "The IOM provides a strong conceptual basis for these changes with the framework emerging from the report," Spinks said. "National coordination and funding will drive metrics that resonate with cancer patients, raising the bar beyond the safe and effective care that should be absolutes in our health care system. Ultimately, it will accelerate improvements in cancer care where other programs have failed."

Intelligent redesign in action

As the nation's largest cancer center with more than 32,000 new patients each year, MD Anderson is among the first to work toward identifying significant value-based outcomes for cancer patients and providers, through its Institute for Cancer Care Innovation.

The institute initiated its first comprehensive pilot project in 2008, collaborating with Michael E. Porter and the Harvard Business School. Their work in MD Anderson's Head and Neck Center resulted in a better understanding of what outcomes were important to patients and how best to gather and disseminate that information.

They're expanding this pilot to include patient focus groups for each multidisciplinary care center at the institution. This is the first phase of a two-year grant from the Arthur Vining Davis Foundation intended to narrow the outcomes that matter most to patients. The second phase, launching this year, will create a survey tool linked to MD Anderson's electronic health records that can better report patient outcomes and capture real-time patient needs.

Intelligent redesign is a concept first coined by Robert S. Kaplan of the Harvard Business School in a joint publication with the Institute for Cancer Care Innovation. MD Anderson is at the forefront of national and international efforts to reshape cancer care delivery so that it promotes value that is meaningful to patients, providers and insurers. Read more on the institute's initiatives underway in their latest newsletter.

Explore further: Patient empowerment and system transformation to improve cancer care

Related Stories

Patient empowerment and system transformation to improve cancer care

December 14, 2011
Physicians can use medical records to track the quality of cancer care and determine whether their patients are receiving the right treatments at the right time. Yet the patient is the only one who ultimately can evaluate ...

Childhood cancer survivors experience a gap in care

January 24, 2014
A recent study shows that many internists feel ill-equipped to care for adult patients who are childhood cancer survivors. Eugene Suh, MD, assistant professor in the division of Pediatric Hematology & Oncology at Loyola University ...

US faces crisis in cancer care, says new IOM report

September 10, 2013
Delivery of cancer care in the U.S. is facing a crisis stemming from a combination of factors—a growing demand for such care, a shrinking oncology work force, rising costs of cancer care, and the complexity of the disease ...

Costs for complications from cancer surgical care extremely high

January 6, 2014
Although complications from surgical care for cancer patients may seem infrequent, the costs associated with such outcomes are extremely high, according to researchers from Rice University's Baker Institute for Public Policy ...

Cancer risk for aging Baby Boomers

December 2, 2013
As 10,000 baby boomers reach 65 each day, the incidence of cancer is increasing, estimated to increase by 67% between 2010 and 2030, bringing attention to the nation's response to cancer care. Cancer is diagnosed at a higher ...

ASCO issues recommendations to improve cancer survivor care

January 10, 2013
(HealthDay)—The American Society of Clinical Oncology (ASCO) has presented recommendations for promoting high-quality cancer survivorship care in a report published online Jan. 7 in the Journal of Clinical Oncology.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.